Alterity Therapeutics (ATHE) Net Income towards Common Stockholders Growth (3y) (2019 - 2020)

Alterity Therapeutics (ATHE) Net Income towards Common Stockholders Growth (3y) (2019 - 2020) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 84.25%
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -10.84%
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 26.38%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 34.98%
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -46.86%
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 13.80%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Regeneron Pharmaceuticals 63.43 Bn 54.67 Bn 3.31 Bn -3.84%

Historic Data

Download Data
DateValue
Dec 31, 2020 61.97%
Dec 31, 2019 -12.04%